NCT05784402 - A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants | Biotech Hunter

Enrollment

264

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

February 23, 2024

Study Completion Date

March 29, 2024

Conditions

Healthy Participants

Interventions

DRUG

Semaglutide J

Participants will receive oral semglutide J at dose level 1 and 3 in treatment sequence A and C; and at dose level 2 and 4 in treatment sequence B and D.

DRUG

Semaglutide C

Participants will receive oral semglutide C in treatment sequence A and B; and at semglutide C at 2x dose level in treatment sequence C and D.

Trial Locations (2)

90630

Altasciences Clinical LA, Inc., Cypress

H3P 3P1

Altasciences Clinical Company, Inc, Montreal